We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plant-Derived Culture Media

By HospiMedica staff writers
Posted on 27 Jul 2005
A new plant-derived recombinant growth factor for cell culture media promotes productivity and safety.

Called Lacromin, the growth factor is a recombinant human lactoferrin derived from plants, which outperforms transferrin, a common animal-derived growth factor. More...
Lacromin is the product of Ventria Bioscience (Sacramento, CA, USA).

Lacromin is a strong growth factor that has promoted cell growth in many cell lines, including Chinese hamster ovary (CHO) cells and mouse hybridoma cells. The growth factor also promotes higher cell density and reduces cell doubling time when compared to transferrin. Since Lacromin is derived from plants, it is free of any viral or prion containment risks. In hybriderma cells, Lacromin increased IgG productivity by 50% compared to transferrin and by 6% compared to fetal bovine serum (FBS).

"We are very encouraged by the positive results we have generated on Lacromin,” said Ning Huang, vice president of research and development, Ventria Bioscience. Mr. Huang introduced Lacromin at the Raw Materials and Disposable Process Systems for Mammalian Cell Culture Products Conference in Kansas City (MO, USA) in July 2005. "At the conference today, I presented results showing Lacromin significantly increased the productivity of antibody production when compared with animal-derived transferrin.”

The company will market Lacromin to companies seeking a serum-free and animal component-free cell culture media source.




Related Links:
Ventria Bioscience

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.